These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 33414790)

  • 1. RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?
    Sandbrink JB; Shattock RJ
    Front Immunol; 2020; 11():608460. PubMed ID: 33414790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccines' New Era-RNA Vaccine.
    Zhou W; Jiang L; Liao S; Wu F; Yang G; Hou L; Liu L; Pan X; Jia W; Zhang Y
    Viruses; 2023 Aug; 15(8):. PubMed ID: 37632102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
    Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
    Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccine development and a potential nanomaterial path forward.
    Shin MD; Shukla S; Chung YH; Beiss V; Chan SK; Ortega-Rivera OA; Wirth DM; Chen A; Sack M; Pokorski JK; Steinmetz NF
    Nat Nanotechnol; 2020 Aug; 15(8):646-655. PubMed ID: 32669664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases.
    Rouf NZ; Biswas S; Tarannum N; Oishee LM; Muna MM
    RNA Biol; 2022; 19(1):386-410. PubMed ID: 35354425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid development and deployment of high-volume vaccines for pandemic response.
    Kis Z; Kontoravdi C; Dey AK; Shattock R; Shah N
    J Adv Manuf Process; 2020 Jul; 2(3):e10060. PubMed ID: 33977274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
    Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
    EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
    Xia S; Duan K; Zhang Y; Zhao D; Zhang H; Xie Z; Li X; Peng C; Zhang Y; Zhang W; Yang Y; Chen W; Gao X; You W; Wang X; Wang Z; Shi Z; Wang Y; Yang X; Zhang L; Huang L; Wang Q; Lu J; Yang Y; Guo J; Zhou W; Wan X; Wu C; Wang W; Huang S; Du J; Meng Z; Pan A; Yuan Z; Shen S; Guo W; Yang X
    JAMA; 2020 Sep; 324(10):951-960. PubMed ID: 32789505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
    Gudadappanavar AM; Benni J
    J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology.
    Ye Z; Harmon J; Ni W; Li Y; Wich D; Xu Q
    ACS Nano; 2023 Aug; 17(16):15231-15253. PubMed ID: 37535899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-amplifying mRNA vaccines.
    Brito LA; Kommareddy S; Maione D; Uematsu Y; Giovani C; Berlanda Scorza F; Otten GR; Yu D; Mandl CW; Mason PW; Dormitzer PR; Ulmer JB; Geall AJ
    Adv Genet; 2015; 89():179-233. PubMed ID: 25620012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging vaccine delivery systems for COVID-19: Functionalised silica nanoparticles offer a potentially safe and effective alternative delivery system for DNA/RNA vaccines and may be useful in the hunt for a COVID-19 vaccine.
    Theobald N
    Drug Discov Today; 2020 Sep; 25(9):1556-1558. PubMed ID: 32592866
    [No Abstract]   [Full Text] [Related]  

  • 16. A Thermostable mRNA Vaccine against COVID-19.
    Zhang NN; Li XF; Deng YQ; Zhao H; Huang YJ; Yang G; Huang WJ; Gao P; Zhou C; Zhang RR; Guo Y; Sun SH; Fan H; Zu SL; Chen Q; He Q; Cao TS; Huang XY; Qiu HY; Nie JH; Jiang Y; Yan HY; Ye Q; Zhong X; Xue XL; Zha ZY; Zhou D; Yang X; Wang YC; Ying B; Qin CF
    Cell; 2020 Sep; 182(5):1271-1283.e16. PubMed ID: 32795413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development.
    Huang SW; Tai CH; Hsu YM; Cheng D; Hung SJ; Chai KM; Wang YF; Wang JR
    Biomed J; 2020 Aug; 43(4):375-387. PubMed ID: 32611537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new generation of vaccines based on alphavirus self-amplifying RNA.
    Ballesteros-Briones MC; Silva-Pilipich N; Herrador-Cañete G; Vanrell L; Smerdou C
    Curr Opin Virol; 2020 Oct; 44():145-153. PubMed ID: 32898764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comprehensive Review of mRNA Vaccines.
    Gote V; Bolla PK; Kommineni N; Butreddy A; Nukala PK; Palakurthi SS; Khan W
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36769023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [At least 68 vaccine candidates under development].
    Leach S
    Lakartidningen; 2020 Apr; 117():. PubMed ID: 32293018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.